Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

MODY12 Diabetes

MODY12 ist ein autosomal dominanter einsetzender Typ 2 Diabetes, der sich aufgrund einer Mutation im Gen ABCC8 entwickelt. In der pathogenese kommt es zuerst zu einer überschießenden Insulinsekretion was später zu einer Erschöpfung der beta-Zelle und damit zur Entwicklung eines Diabetes führt.

Klinischer Befund

Mit seinem milderen klinischen Verlauf ähnelt der MODY Typ 12 eher dem MODY2. Im Unterschied zu diesem entwickelt er sich aber aus einer anfänglichen Insulinhypersekretion.

Gliederung

MODY Diabetes
MODY1 Diabetes
MODY10 Diabetes
MODY11 Diabetes
MODY12 Diabetes
ABCC8
MODY13 Diabetes
MODY14 Diabetes
MODY2 Diabetes
MODY3 Diabetes
MODY4 Diabetes
MODY5 Diabetes
MODY6 Diabetes
MODY7 Diabetes
MODY8 Diabetes
MODY9 Diabetes

Referenzen:

1.

Goksel DL et al. (1998) Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR-1 gene variant and hyperinsulinemia.

external link
2.

Glaser B et al. (1999) Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene.

external link
3.

Giurgea I et al. (2006) The Knudson's two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism.

external link
4.

Thomas PM et al. (1995) Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy.

external link
5.

Fantes JA et al. (1995) A high-resolution integrated physical, cytogenetic, and genetic map of human chromosome 11: distal p13 to proximal p15.1.

external link
6.

Glaser B et al. (1994) Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene.

external link
7.

Philipson LH et al. (1995) Pas de deux or more: the sulfonylurea receptor and K+ channels.

external link
8.

Aguilar-Bryan L et al. (1995) Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.

external link
9.

Inoue H et al. (1996) Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.

external link
10.

Gribble FM et al. (1997) The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide.

external link
11.

Nestorowicz A et al. (1998) Genetic heterogeneity in familial hyperinsulinism.

external link
12.

Laukkanen O et al. (2004) Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study.

external link
13.

Ryan F et al. (1998) Hyperinsulinism: molecular aetiology of focal disease.

external link
14.

Matsuo M et al. (2000) Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy.

external link
15.

Reis AF et al. (2000) Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians.

external link
16.

Meirhaeghe A et al. (2001) Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.

external link
17.

Pocai A et al. (2005) Hypothalamic K(ATP) channels control hepatic glucose production.

external link
18.

Simard JM et al. (2006) Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.

external link
19.

de Wet H et al. (2007) Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.

external link
20.

Banerjee I et al. (2011) The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.

external link
21.

Flanagan S et al. (2012) Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.

external link
22.

Flanagan SE et al. (2013) Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation.

external link
23.

Nestorowicz A et al. (1996) Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews.

external link
24.

Thornton PS et al. (1998) Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant.

external link
25.

Proks P et al. (2006) A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.

external link
26.

Babenko AP et al. (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.

external link
27.

Otonkoski T et al. (1999) A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.

external link
28.

Huopio H et al. (2000) Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.

external link
29.

Huopio H et al. (2003) A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1.

external link
30.

Thornton PS et al. (2003) Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor.

external link
31.

Tornovsky S et al. (2004) Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.

external link
32.

Thomas PM et al. (1995) Homozygosity mapping, to chromosome 11p, of the gene for familial persistent hyperinsulinemic hypoglycemia of infancy.

external link
33.

Thomas PM et al. (1996) Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy.

external link
34.

Lohmueller KE et al. (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.

external link
35.

Verkarre V et al. (1998) Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia.

external link
36.

Dunne MJ et al. (1997) Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor.

external link
37.

Glaser B et al. (1999) Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism.

external link
38.

Magge SN et al. (2004) Familial leucine-sensitive hypoglycemia of infancy due to a dominant mutation of the beta-cell sulfonylurea receptor.

external link
39.

Ellard S et al. (2007) Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects.

external link
40.

Henwood MJ et al. (2005) Genotype-phenotype correlations in children with congenital hyperinsulinism due to recessive mutations of the adenosine triphosphate-sensitive potassium channel genes.

external link
41.

Pinney SE et al. (2008) Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.

external link
42.

de Lonlay P et al. (1997) Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy.

external link
43.

Inagaki N et al. (1995) Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.

external link
44.

OMIM.ORG article

Omim 600509 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz